Evidence map›Paper›PMID 20607607›Full record

ArticlePharmacy world & science : PWS2010

GPs' views on patient drug use and the pharmacist's role in DRP management.

Tommy Westerlund, Jan-Olof Brånstad

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmacy world & science : PWS, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Tommy WesterlundResearch and Development, Apoteket AB, PO Box 1052, SE 251 10, Helsingborg, Sweden. tommy.westerlund@gmail.com
Jan-Olof Brånstad
Helsingborgs lasarett · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to examine general practitioners' (GPs') views on (1) patients' drug-related problems (DRPs) and noncompliance and (2) the role of pharmacy practitioners in DRP management.

methodA brief questionnaire was designed and distributed to 224 GPs in Sweden.

resultsTotally 152 GPs responded (68%). Most felt that pharmacy practitioners could improve patients' drug use by identifying DRPs. A majority of the GPs also found presentations and analyses of their local pharmacies' DRP documentation valuable. According to the GPs' experiences, adverse drug effects and therapy failure were the most salient problems in patients' drug use. Half of the doctors believed that 50-75% of their patients were compliant with their prescribed drug treatments. A majority of the GPs found a 75-95% degree of compliance acceptable.

conclusionThe surveyed GPs demonstrated very positive attitudes towards the role of pharmacy practitioners in improving patients' drug use and managing DRPs. The GPs realised that many patients were not compliant with their prescribed drug treatments and accepted an imperfect compliance.

Indexed as

Attitude of Health PersonnelGeneral PractitionersInterprofessional RelationsPharmacistsCommunity Pharmacy ServicesDrug-Related Side Effects and Adverse ReactionsDrug UtilizationHumansMedication Therapy ManagementPatient ComplianceSurveys and QuestionnairesSweden

Identifiers

PMID20607607
OpenAlexW1977922630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.